Medications for Opioid Use Disorder in WA State Jails Series

Medications for Opioid Use Disorder in Washington State Jails, Part 1

Opioid Use Disorder & Medications for Opioid Use Disorder

Presenter(s): Mandy Owens, PhD, UW Addictions, Drug & Alcohol Institute (ADAI)
Date: November 2020
Shareable link to this video

The first module in this training provides a brief introduction to opioid use disorder and medications for opioid use disorder. This module is intended for a jail staff audience, including corrections officers. It discusses: the important distinction between opioid dependence and opioid use disorder; the three FDA-approved medications, methadone, buprenorphine, and naltrexone; and common concerns related to medications for opioid use disorder.

Medications for Opioid Use Disorder in Washington State Jails, Part 2

The Role of Medications for Opioid Use Disorder in Jails

Presenter(s): Lt. Penelope Sapp (Kitsap County Jail), Comm. Stephen Sultemeier (Franklin County Jail), and Mandy Owens, PhD (UW ADAI).
Date: March 2021
Shareable link to this video

This second module of this training series from two Washington State jails, the Kitsap County Jail and Franklin County Jail. Lt. Sapp and Comm. Sultemeier offer their rationales for starting an MOUD program at their facilities. They discuss the benefits they have seen of an MOUD program to the people who incarcerated, jail staff, and their communities. Last, Dr. Owens describes how starting people on MOUD can reduce their risk of overdose after release from jail.

Medications for Opioid Use Disorder in Washington State Jails, Part 3

Common Concerns Related to Medications for Opioid Use Disorders in Jails

Presenter(s): Lt. Penelope Sapp (Kitsap County Jail), Victor Mendez (Family Health Centers – Omak), and Mandy Owens, PhD (UW ADAI)
Date: March 2021
Shareable link to this video

This third module of the training series addresses common concerns related to MOUD programs in jails, including: “Aren’t you replacing one drug for another?”, “What about diversion?”, and “I just see the same people coming back to jail”. Dr. Owens reviews the difference between opioid dependence and opioid use disorder that was discussed in Part 1. Lt. Sapp returns to share how the benefits of their MOUD program have outweighed risks of diversion. In conclusion, Victor shares his story that includes 25 years of incarceration and how MOUD helped him recover from opioid use disorder.